Gene · 690
Papers2,843
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,843
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Icariin Treatment Rescues Diabetes Induced Bone Loss via Scavenging ROS and Activating Primary Cilia/Gli2/Osteocalcin Signaling Pathway. | Cells | 2022 | 36552853 | PubTator, text mining | PubMed |
| Xianling Gubao attenuates high glucose-induced bone metabolism disorder in MG63 osteoblast-like cells. | PLoS One | 2022 | 36548302 | PubTator, text mining | PubMed |
| Periodontal ligament stem cell-based bioactive constructs for bone tissue engineering. | Front Bioeng Biotechnol | 2022 | 36532583 | PubTator, text mining | PubMed |
| Proximity to major roads and the incidence of osteoporotic fractures in elderly women: The BONE study in Beijing. | Front Public Health | 2022 | 36530693 | PubTator, text mining | PubMed |
| Long Bones Exhibit Adaptive Responses to Chronic Low-Dose-Rate Ionizing Radiation despite its Lifespan-Shortening and Carcinogenic Effects on C57BL/6 Mice. | JBMR Plus | 2022 | 36530184 | PubTator, text mining | PubMed |
| Primary cilia: The central role in the electromagnetic field induced bone healing. | Front Pharmacol | 2022 | 36523493 | PubTator, text mining | PubMed |
| Acupuncture for Osteoporosis: a Review of Its Clinical and Preclinical Studies. | J Acupunct Meridian Stud | 2022 | 36521826 | PubTator, text mining | PubMed |
| An interleukin-1 polymorphism additionally intensified by atopy as prognostic factor for aseptic non-mechanical complications in metal knee and hip arthroplasty. | Front Immunol | 2022 | 36518750 | PubTator, text mining | PubMed |
| Immunohistochemistry of resorption and inflammation factors in the periodontal ligament of human deciduous teeth. | Braz Oral Res | 2022 | 36507743 | PubTator, text mining | PubMed |
| Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease. | Front Endocrinol (Lausanne) | 2022 | 36506070 | PubTator, text mining | PubMed |
| The inflammatory response, a mixed blessing for muscle homeostasis and plasticity. | Front Physiol | 2022 | 36505042 | PubTator, text mining | PubMed |
| Blackcurrants Reduce the Risk of Postmenopausal Osteoporosis: A Pilot Double-Blind, Randomized, Placebo-Controlled Clinical Trial. | Nutrients | 2022 | 36501004 | PubTator, text mining | PubMed |
| Advances in Molecular Pathology of Obstructive Sleep Apnea. | Molecules | 2022 | 36500515 | PubTator, text mining | PubMed |
| Exploring the Role of Sclerostin as a Biomarker of Cardiovascular Disease and Mortality: A Scoping Review. | Int J Environ Res Public Health | 2022 | 36498053 | PubTator, text mining | PubMed |
| An effect comparison of alendronate and teriparatide in patients with glucocorticoid-induced osteoporosis: A protocol for systematic review and meta-analysis. | Medicine (Baltimore) | 2022 | 36482548 | PubTator, text mining | PubMed |
| Extracellular vesicles: A potential future strategy for dental and maxillofacial tissue repair and regeneration. | Front Physiol | 2022 | 36479350 | PubTator, text mining | PubMed |
| Circadian clock-A promising scientific target in oral science. | Front Physiol | 2022 | 36467684 | PubTator, text mining | PubMed |
| Zeolites: A series of promising biomaterials in bone tissue engineering. | Front Bioeng Biotechnol | 2022 | 36466336 | PubTator, text mining | PubMed |
| Bisphosphonate-loaded bone cement: Background, clinical indications and future perspectives. | J Musculoskelet Neuronal Interact | 2022 | 36458394 | PubTator, text mining | PubMed |
| The regulatory activities of MALAT1 in the development of bone and cartilage diseases. | Front Endocrinol (Lausanne) | 2022 | 36452326 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/690/papers?page=39